F or >30 years, 1,2 there has been controversy regarding the clinical significance of low diastolic blood pressure (DBP) in patients treated for hypertension because it relates to increased cardiovascular disease (CVD) risk in general and to coronary heart disease (CHD) risk in particular. This has not been studied in those with pre-existing CVD, a population with greater risk than those without initial events. Therefore, in the present study, we limited our investigation to persons who survived an initial CVD event-CHD, heart failure (HF), or stroke. We divided these persons into 2 groups: (1) those with isolated systolic hypertension (ISH; systolic blood pressure [SBP] ≥140 and DBP <90 mm Hg) with DBP 70 to 89 mm Hg, in the presence or absence of antihypertensive treatment; these persons are at higher risk because of widened pulse pressure and increased arterial stiffness [3] [4] [5] ; and (2) persons with ISH with a low mean arterial pressure that is associated with a low DBP, ie, <70 mm Hg in the absence or presence of antihypertensive treatment 6, 7 ; we hypothesized that group 2 persons would be at even higher risk than group 1.
F or >30 years, 1, 2 there has been controversy regarding the clinical significance of low diastolic blood pressure (DBP) in patients treated for hypertension because it relates to increased cardiovascular disease (CVD) risk in general and to coronary heart disease (CHD) risk in particular. This has not been studied in those with pre-existing CVD, a population with greater risk than those without initial events. Therefore, in the present study, we limited our investigation to persons who survived an initial CVD event-CHD, heart failure (HF), or stroke. We divided these persons into 2 groups: (1) those with isolated systolic hypertension (ISH; systolic blood pressure [SBP] ≥140 and DBP <90 mm Hg) with DBP 70 to 89 mm Hg, in the presence or absence of antihypertensive treatment; these persons are at higher risk because of widened pulse pressure and increased arterial stiffness [3] [4] [5] ; and (2) persons with ISH with a low mean arterial pressure that is associated with a low DBP, ie, <70 mm Hg in the absence or presence of antihypertensive treatment 6, 7 ; we hypothesized that group 2 persons would be at even higher risk than group 1.
We addressed the following questions in the present investigation: First, is there increased risk for recurrent CVD events in individuals with a DBP of <70 mm Hg versus those with a DBP 70 to 89 mm Hg in those with ISH, regardless of the presence or absence of antihypertensive treatment? Second, is there increased risk for individual CVD components examined separately (CHD, HF, or stroke events) in the presence versus absence of antihypertensive treatment in individuals with a DBP of <70 mm Hg versus a DBP 70 to 89 mm Hg? Third, can we judge the relative importance of wide pulse pressure versus low DBP in predicting CVD events?
Methods

Overview
The Framingham Heart Study began in 1948 enrolling 5209 men and women, 30 to 62 years of age who underwent repeated examinations biennially. [8] [9] [10] In 1971, 5124 men and women who were children or the spouses of children of the original Framingham Heart Study were 300
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February 2015 enrolled in the Framingham Offspring cohort. 11 The offspring cohort underwent repeated examinations every 4 years. A detailed description of this study design, the method for assessing BP, and the method of classifying CVD end points have been published elsewhere. 12, 13 Initial and recurrent CVD events consisted of CHD (myocardial infarctions, coronary insufficiency, or sudden cardiac death), HF, or stroke. Inclusion criteria included postprimary CVD event survivors with the presence of ISH, with or without receiving antihypertensive treatment. Exclusion criteria were the absence of a study visit within 5-year postinitial CVD event.
Study Sample
As shown in the flow diagram (Figure 1 ), inclusion criteria resulted in 791 participants who survived their initial CVD event, appeared for ≥1 postinitial CVD event visit within 5 year of their initial event, and had evidence of ISH. There were an additional 130 initial CVD event survivors that were excluded from the analysis: 121 had insufficient risk factor covariates for Cox regression modeling and 19 had their first visits beyond the 5-years postinitial CVD exclusion criterion. Of the initial 791 event survivors with postinitial event visits, 367 were without recurrent CVD events and therefore were censored: 72 with DBP <70 mm Hg and 295 with DBP 70 to 89 mm Hg. Of the 424 subjects with recurrent CVD events, 153 had DBP <70 mm Hg and 271 had DBP 70 to 89 mm Hg. We began the study with the second biannual examination (1950) and extended it through 2005. Because of the long duration of the study, we tested for secular trend by adjusting for consecutive decades of occurrence of index primary events (<1960s, 1960-1969, 1970-1979 , ≥1980).
Assessment of Risk Factors and Cardiovascular Events
Current cigarette smoking was defined as regularly smoking cigarettes at any time during the prior year. Body mass index was calculated as body weight (in kilograms) divided by the square of height (in meters). A fasting blood glucose level of ≥7.0 mmol/L (126 mg/dL; in the offspring cohort), a nonfasting glucose of ≥11.0 mmol/L (≥200 mg/dL; in the original cohort), or the use of hypoglycemic medications (in both cohorts) defined diabetes mellitus, and serum cholesterol (high-density lipoprotein cholesterol was not included because it was not available for baseline visits before 1970). Hypertensive treatment refers to any medication(s) prescribed specifically for hypertension at the examination after the primary CVD event and before the recurrent CVD event; in the absence of this information, the participant was defined as not receiving antihypertensive therapy.
Data Analysis
At the first available visit after the initial event, comparisons were made between participants with DBP <70 versus DBP 70 to 89 mm Hg (Table 1 ). In addition, the 826 individuals who had secondary events without visits between their initial and recurrent events did not qualify for Cox regression analysis; nevertheless, we compared characteristics of these 826 with 424 persons with visits and recurrent events. Comparisons between various groups utilized χ 2 for categorical analysis and paired t-tests for continuous data.
Cox regression models were performed calculating hazard ratios (HRs) and 95% confidence intervals (CIs) (1) unadjusted, (2) adjusted for age and sex, and (3) adjusted additionally for body mass index, total cholesterol, smoking, and diabetes mellitus to test the relation of DBP <70 mm Hg versus DBP 70 to 89 mm Hg for recurrent CVD event risk (CHD, HF, and stroke events) examined together and separately as individual events in models for (1) combined antihypertensive treated and untreated, (2) antihypertensive treated, and (c) untreated individuals. All models were stratified by quintiles of time from the date of the primary CVD event to the first postexamination visit (cut points for quintiles in days were <165, 166-317, 318-471, 472-650, and 651-1806). Last, interaction terms were added to test for homogeneity of the DBP effect by treatment status.
To judge the potential modifying effect of wide pulse pressure on excess risk associated with low DBP, we defined 4 groups from binary groupings of median pulse pressure (≥68 verses <68 mm Hg) and categorical DBP (<70 versus 70-89 mm Hg), followed by Cox modeling with those in the lowest pulse pressure DBP group defined as reference category. 
Results
Comparison
Comparison Between Individuals With Visits Versus Without Visits Between Events
Participants without visits between initial and recurrent events were older by 5.2 years than in those with visits between events (P<0.01). The most striking difference in those without visits between events was the close temporal relation between initial and recurrent CVD events: 47% of treated and 42% of untreated recurrent CVD events occurred within 1 week of the initial CVD events (P<0.01); 64% of the treated and 56% of untreated subjects occurred within 1 month of the initial events (P<0.01). The mean follow-up time to recurrent events was 1.9 years in those without visits between events and 7.9 years in those with ≥1 visits between events (P<0.01). The proportion of the 3 types of recurrent CVD events (CHD, HF, and stroke) did not differ between those with and without postinitial visits. However, CVD deaths were significantly more common in people without postinitial CVD event visits (40% 
Bivariate Analysis
Of 791 hypertensive participants (mean age 75 years, female 47%), who survived their initial CVD event, 225 (28%) had DBP <70 mm Hg and 566 (72%) had DBP 70 to 89 mm Hg, of which 153 of 225 (68%) and 271 of 566 (48%), respectively, experienced CVD events (P<0.0001). The mean follow-up time between the initial and recurrent events was 8.0±6 years.
Cox Proportional Hazard Regression Modeling
There was an increased risk of recurrent CVD events in risk factor-adjusted Cox regression models with DBP <70 mm Hg versus DBP 70 to 89 mm Hg in combined treated and untreated persons (HR, 5.9 [95% CI, 4.6-7.5] P<0.0001) after adjusting for age, sex, body mass index, total cholesterol, smoking, and diabetic status (Tables 2-4; Figure 2 
Wide Pulse Pressure Modifies the Effect of Low DBP on CVD Risk
For the 791 postinitial CVD event survivors, the combination of pulse pressure ≥68 together with DBP <70 mm Hg had the highest incidence of subjects who developed CVD events ( Figure 3) . In Cox regression, with the lowest pulse pressure-DBP grouping as the reference category, the adjusted HR for DBP <70 mm Hg and pulse pressure ≥68 mm Hg was 2.40 (95% CI: 1.6-3.7) P<0.0001, consistent with the hypothesis that increased CVD risk was associated with DBP <70 mm Hg only when combined with a pulse pressure of ≥68 mm Hg.
Discussion
In a previous Framingham report, 14 we showed that middleaged and older individuals with ISH in the absence of prior CVD events (CHD, HF, or stroke) and without antihypertensive treatment were at greater CVD risk in the presence of DBP <70 versus DBP 70 to 89 mm Hg; these conclusions were confirmed by the Monica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project study. 15 Our present investigation is the first community-based study to show that both treated and untreated individuals with ISH and DBP <70 mm Hg were at greater risk for recurrent CVD events than those with DBP 70 to 89 mm Hg. Second, similar findings were present when examining single CVD end points of CHD, HF, or stroke. Third, CVD event rates were highest in the group with widened pulse pressure and DBP <70 mm Hg compared with those with both low pulse pressure and low DBP, whether treated or untreated, supporting wide pulse pressure as an important risk modifier of the adverse effect from low DBP. We have previously shown in US adults 16 that DBP <70 mm Hg is present in 30% of untreated persons with ISH ( versus 35% in treated). There was a 3-fold greater prevalence of CVD events from the highest to the lowest DBP strata in untreated ISH. Furthermore, advanced age, female sex, and diabetes mellitus, but not treatment status, were associated with low DBP. Similarly, Ungar et al 17 showed that low ambulatory DBP was associated with greater all-cause mortality in older patients with ISH after adjusting for antihypertensive treatment and other covariates. The Framingham Heart Study 14 showed that a DBP of <70 mm Hg versus DBP 70 to 89 mm Hg in the absence of antihypertensive therapy could add a risk equivalent of ≈20 mm Hg of increase in SBP-in other words, a potential risk-equivalent shift from prehypertension to stage 1 systolic hypertension or from stage 1 to stage 2 systolic hypertension. Moreover, as shown by Wang et al, 18 antihypertensive therapy will maximize the decrease in SBP and minimize the reduction in DBP in direct proportion to age-related widening of pulse pressure. Therefore, not only is DBP <70 mm Hg common and associated with increased CVD risk in untreated elderly persons with ISH but also antihypertensive therapy has only a minimal effect in further lowering of DBP compared with the lowering of SBP.
Antihypertensive Treatment as a Cause of Recurrent CHD Events
Because post hoc analyses of intervention trials are fraught with bias and confounding, they cannot answer whether antihypertensive treatment induces CHD events in the presence of a low DBP.
19-21 DBP declines with age, female sex, diabetes mellitus, chronic kidney disease, HF, incident cancer, and 22 noted that CHD events in persons with low DBP were mainly in those with increased SBP, suggesting that ISH with increased pulse pressure may have been responsible, rather than the presence of antihypertensive treatment. Importantly, excessive treatment was not likely the cause of the low DBP because a lower frequency of treatment was related to a lower DBP. 22 Furthermore, antihypertensive therapy in an elderly person with ISH preferentially decreases SBP over DBP, 18, 20 lowers pulse pressure, decreases arterial stiffness, and therefore theoretically may improve the coronary oxygen supply/demand ratio of the left ventriclethereby providing protection from ischemia. The Framingham Heart Study results 22 have been confirmed by the Cardiovascular Research Using Linked Bespoke Studies and Electronic Health Records (CALIBER) program (Linked Bespoke studies and the Electronic health Records of 1.25 million patients), which showed an absence of DBP J-curve except when accompanied by SBP ≥140 mm Hg. 23 Taken together, the findings in this study suggest that antihypertensive treatment was not related to recurrent CHD events. First, the increase in CVD risk with DBP <70 mm Hg versus DBP 70 to 89 mm Hg was equally distributed in treated and untreated persons. Second, the increased CVD risk in association with DBP <70 mm Hg versus DBP n=791 for all Cox models; strata (quintiles) were determined using time between primary event and first postprimary event visit. BMI indicates body mass index; CI, confidence interval; CVD, cardiovascular disease; DBP, diastolic blood pressure; and HR, hazard ratio.
*Adjusted for age per SD, sex (male vs female), BMI (per SD), total cholesterol (per SD), smoking (yes vs no), and diabetes mellitus (yes vs no). 70 to 89 mm Hg was present separately for CHD, HF, and stroke outcomes. Third, the absence of interaction by treatment status for both total and individual CVD events post-DBP <70 mm Hg versus DBP 70-89 mm Hg represented further evidence that the increased CHD event rate was not treatment induced. In summary, this study does not support antihypertensive treatment as a significant cause of increased CVD event risk in association with the onset of low DBP.
Significance of Subjects With Recurrent CVD Events Without Return Visits
Of the 826 individuals who did not have visits between their initial and recurrent CVD events, there was a striking difference in clinical course compared with the 424 who did attend ≥1 visits. First, the majority of participants without visits had a significantly shorter duration between events versus those with visits. Second, there was a high mortality occurring in individuals who had their recurrent event soon after their initial event, both off and on antihypertensive treatments. Third, there were comparable mean BPs before preinitial CVD events in both persons with visits (155/84 mm Hg) and without visits (155/80 mm Hg), suggesting that there were few persons with DBP <70 mm Hg before the onset of primary events.
Previous Framingham publications have shown that a significant postinfarction reduction in SBP is an indication of impaired cardiac function. 24 Therefore, we can postulate that many subjects with early recurrent events and high mortality after their initial events had impaired cardiac function and reversed causality. 24, 25 Therefore, those who did attend office visits after their initial event to quality for our study likely had a significant survivor bias in comparison with those with postinitial CVD events without subsequent visits.
Causes of Increased Recurrent CVD Events in Association With Low DBP
Aging plays an important role as an effect modifier in influencing the presence or absence of DBP in predicting CVD risk. 26 From age 60 years onward, there is a shift in favor of pulse pressure over SBP as a predictor of CVD risk; thus, DBP now displays a J-curve of CVD risk in older people with ISH. 26 Traditionally, increased pulse pressure as a marker of large artery stiffness has been shown to be an independent CVD risk factor. [3] [4] [5] After 60 years of age, the fall in DBP and rapid widening of pulse pressure become surrogate markers of arterial stiffness. Furthermore, we postulate that the increase in CVD risk is in part related to a pernicious combination of faulty microvascular function resulting from increased elastic artery stiffness in combination with low diastolic perfusion pressure. Interestingly, our Cox regression analyses showed that low DBP is a much greater contributor to risk than age, sex, body mass index, total cholesterol, smoking, or diabetes, attesting to the singular importance of the combination of wide pulse pressure and low DBP to recurrent CVD risk in persons with initial CVD events.
The J-curve controversy has been recently summarized in 2 articles entitled Aggressive Blood Pressure Lowering is Dangerous: The J-Curve: con side 27 of the argument versus the pro side 28 of the argument. However, neither of the authors considered a low DBP in association with ISH as predisposing to J-curve CVD events.
Strengths and Limitations
The strengths of our investigation include a wide time interval of data collection in initial CVD event survivors and the standardized measurements from the well-characterized Framingham Heart Study. However, in this observational study, we could not control for who received antihypertensive treatment before or after the initial event, nor the type or amount of treatment. Furthermore, although our medication variable specified an antihypertensive indication, these may have been prescribed for both antihypertensive and other cardiovascular indications. Last, we do not have information on physical functioning nor the possible presence of significant orthostatic hypotension. Nevertheless, the results of our Cox regression models with nonsignificant treatment interactions are strong evidence against a treatment-induced effect of low DBP on CVD events. Finally, of the 826 subjects without return visits after their initial CVD events who did not qualify for our main analysis, we can only speculate that many of these individuals had a likelihood of reverse causation with a high mortality rate within a short time after their primary CVD event.
Many factors interact to lower DBP and influence CHD risk, so only an intervention trial including subjects with low DBP, randomized to various active treatment levels of SBP-lowering, can establish whether high-baseline CVD risk can be modified by treatment. Furthermore, the optimal therapeutic reduction in SBP and DBP in the older patient with ISH that maximizes benefit is a separate question from the safety of lowering high SBP in the presence of low DBP. 
Perspective
This is the first community-based study to show that persons with an initial CVD event and persistent isolated systolic hypertension in combination of DBP <70 mm Hg versus DBP 70-89 mmHg had increased risk for recurrent CVD events. These findings support wide pulse pressure in combination with low DBP as important risk factors, largely independent of antihypertensive treatment status. Whether specific risk factor modifications might be considered to address this possible excess risk in such individuals may be the subject of future investigations.
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What Is New?
• Increased recurrent cardiovascular disease risk in persons with isolated systolic hypertension, whether treated or untreated, was related to wide pulse pressure as a risk modifier for the adverse effect of a low diastolic blood pressure <70 mm Hg.
What Is Relevant?
• We postulate that increased cardiovascular disease risk is related to the pernicious effects of faulty microvascular function resulting from increased elastic artery stiffness in combination with low diastolic perfusion pressure.
Summary
Persons with an initial cardiovascular disease event and persistent isolated systolic hypertension, who subsequently have diastolic blood pressure <70 mm Hg versus diastolic blood pressure 70 to 89 mm Hg, have increased risk for a recurrent cardiovascular disease event, supporting wide pulse pressure in combination with low diastolic blood pressure as important risk factors independent of treatment status.
Novelty and Significance
